COMMUNIQUÉS West-GlobeNewswire

HealthLynked Announces Agreement with Availity, the Nation’s Largest Health Benefits Network, to Deliver HealthLynked Members Real-time Benefit Information

18/12/2018 - 14:00

NAPLES, Fla., Dec. 18, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced the company has entered into a master trading partner agreement with Availity, a leader in real-time information [...]

InspireMD Announces Publication of Meta-Analysis Citing Benefits of Next Generation Mesh-Covered Carotid Stent Systems

18/12/2018 - 14:00

Analysis includes clinical studies incorporating the Company’s MicroNet™-covered stent, the CGuard™ Embolic Prevention System (EPS) TEL AVIV, Israel, Dec. 18, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: [...]

Progressive Care Inc. Garners News Coverage in Leading Financial Publications, Yahoo Finance and Benzinga on Its Efforts to End the Opioid Crisis

18/12/2018 - 14:00

MIAMI, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered news coverage in leading financial [...]

Sport Endurance Announces Investment in Nutritional Pet Food Company, TruPet

18/12/2018 - 14:00

BROOKLYN, N.Y., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB: SENZ) (the “Company”), announced today that it has made a $2.2 million investment in TruPet LLC (“TruPet”), the parent company of TruDog, a [...]

Radient Technologies Inc. Announces Commencement of Trading on the OTCQX, Best Market in the United States

18/12/2018 - 13:30

EDMONTON, Alberta, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce that its common shares commenced trading today on the [...]

OpGen Completes CDC Contract to Develop Clinical Support Mobile-Based Tools for Antimicrobial Stewardship and Infection Control

18/12/2018 - 13:30

GAITHERSBURG, Md., Dec. 18, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today announced that it has provided the final report for completion of the contract from the Centers for Disease Control and Prevention ( [...]

ProMIS Neurosciences to Present at Sachs Associates Neuroscience Innovation Forum and China Focus@JPMWeek

18/12/2018 - 13:30

ProMIS to showcase its Alzheimer’s, Parkinson’s and ALS programs at notable biotech investor events TORONTO and CAMBRIDGE, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a [...]

Cellular Biomedicine Group Appoints CAR-T Pioneer Dr. Stephan A. Grupp as Member of Scientific Advisory Board

18/12/2018 - 13:30

SHANGHAI, China and NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc . (NASDAQ: CBMG) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the development of immunotherapies for [...]

Terveystalo Plc: Disclosure under chapter 9, section 10 of the securities market act

18/12/2018 - 13:15

Terveystalo Plc Stock Exchange Release 18 December 2018 at 14:15 EET Terveystalo Plc has received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act from Ilmarinen Mutual [...]

Holding(s) in Company

18/12/2018 - 13:15

TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the [...]

Resonant Inc. Signs New License Agreement with a Leading Chinese Optoelectronics Company that has Targeted the RFFE Market for Expanded Growth

18/12/2018 - 13:05

New customer selects Resonant to shorten time to market for a high performance quadplexer design Becoming second customer to leverage Resonant standard library-based quadplexer filter design GOLETA, Calif., Dec. 18, [...]

AVROBIO, Inc. Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

18/12/2018 - 13:05

CAMBRIDGE, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ: AVRO), (“The Company”) a Phase 2 clinical-stage gene therapy company, today announced the grant of non-qualified stock options to purchase 293, [...]

Axsome Therapeutics to Present at Biotech Showcase 2019

18/12/2018 - 13:00

NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]

AVROBIO, Inc. Expands and Strengthens Leadership Team with Four Senior Management Hires

18/12/2018 - 13:00

Birgitte Volck, M.D., Ph.D., is appointed President of Research and Development and will oversee clinical, regulatory, research and manufacturing CAMBRIDGE, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc . ( [...]

Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement

18/12/2018 - 13:00

NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat [...]

Neuralstem Appoints Ken Carter, Ph.D., as Executive Chairman of the Board

18/12/2018 - 13:00

- Seasoned biotech executive and accomplished scientific leader with broad experience from early-stage company development to managing publicly traded entities - GERMANTOWN, Md., Dec. 18, 2018 (GLOBE NEWSWIRE) -- [...]

Lexicon Pharmaceuticals Announces Positive Topline Clinical Data for LX9211

18/12/2018 - 13:00

THE WOODLANDS, Texas, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced positive topline results from its Phase 1a study of LX9211, a potent oral small molecule inhibitor of [...]

Evogene and TMG Announce Collaboration to Develop Nematode Resistant Soybean through Genome Editing

18/12/2018 - 13:00

Both parties to have commercialization rights REHOVOT, Israel & CAMBÉ, Brazil, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life [...]

Transactions in relation to share buyback program

18/12/2018 - 12:56

Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]